Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-stage Invasive Lobular Breast Carcinoma”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableWithdrawnNCT01960803
What this trial is testing

Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)

Who this might be right for
Invasive Ductal Breast CancerCarcinoma Breast Stage I
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Not applicableActive Not RecruitingNCT01644669
What this trial is testing

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma in Situ
Xoft, Inc. 1,200
Early research (Phase 1)Study completedNCT00749437
What this trial is testing

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 34
Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Testing effectiveness (Phase 2)Study completedNCT03345420
What this trial is testing

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage 0 Breast Cancer+6 more
University of Utah 102
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Large-scale testing (Phase 3)Study completedNCT01426880
What this trial is testing

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 595
Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Very early researchEnded earlyNCT01138553
What this trial is testing

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ
University of California, San Diego 4
Not applicableStudy completedNCT00388115
What this trial is testing

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, Davis 15
Not applicableStudy completedNCT00694577
What this trial is testing

Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer

Who this might be right for
Ductal Breast Cancer
Massachusetts General Hospital 324
Not applicableEnded earlyNCT04088435
What this trial is testing

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, Invasive DuctalInvasive Mammary Carcinoma+2 more
University of Louisville 10
Very early researchStudy completedNCT00527293
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 29
Not applicableLooking for participantsNCT04959474
What this trial is testing

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage 2 Breast Cancer AJCC v8+4 more
Thomas Jefferson University 80
Not applicableWithdrawnNCT04349111
What this trial is testing

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma In Situ
Xoft, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023967
What this trial is testing

Metformin and Nightly Fasting in Women With Early Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Breast Ductal Carcinoma In Situ+1 more
M.D. Anderson Cancer Center 120
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Next Page